Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)

Ischemic stroke is one of the main causes of death and disablement globally. The NLR family pyrin domain containing 3 (NLRP3) inflammasome is established as a sensor of detecting cellular damage and modulating inflammatory responses to injury during the progress of ischemic stroke. Inhibiting or blo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular medicine 2018-12, Vol.42 (6), p.2979-2990
Hauptverfasser: Ma, Chongyang, Liu, Shuling, Zhang, Shuang, Xu, Tian, Yu, Xue, Gao, Yushan, Zhai, Changming, Li, Changxiang, Lei, Chaofang, Fan, Shuning, Chen, Yuxi, Tian, Huiling, Wang, Qingguo, Cheng, Fafeng, Wang, Xueqian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2990
container_issue 6
container_start_page 2979
container_title International journal of molecular medicine
container_volume 42
creator Ma, Chongyang
Liu, Shuling
Zhang, Shuang
Xu, Tian
Yu, Xue
Gao, Yushan
Zhai, Changming
Li, Changxiang
Lei, Chaofang
Fan, Shuning
Chen, Yuxi
Tian, Huiling
Wang, Qingguo
Cheng, Fafeng
Wang, Xueqian
description Ischemic stroke is one of the main causes of death and disablement globally. The NLR family pyrin domain containing 3 (NLRP3) inflammasome is established as a sensor of detecting cellular damage and modulating inflammatory responses to injury during the progress of ischemic stroke. Inhibiting or blocking the NLRP3 inflammasome at different stages, including expression, assembly, and secretion, may have great promise to improve the neurological deficits during ischemic stroke. The current review provides a comprehensive summary of the current understanding in the literature of the molecular structure, expression, and assembly of the NLRP3 inflammasome, and highlights its potential as a novel therapeutic target for ischemic stroke.
doi_str_mv 10.3892/ijmm.2018.3911
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2127559842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2127559842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-9265df3d902f8751e1df4008ea46929527d81338d7f13a26d3f87415ff045e4b3</originalsourceid><addsrcrecordid>eNo9kE1P3DAQhq2KqrvQXntElrjAIVt_JvaxQrQgrVqEisQt8sbjXS9JnNreRfwG_nQTFnqaV5pnXmkehL5SsuBKs29-23ULRqhacE3pBzSnlaYFE-LhaMyUVAWvZDlDxyltCWFSaPUJzThhilDN5-jlau8t9A1g01s8QEwDNNnvAbsQcd4AjqEFHNxr_rW8u-XY9641XWdS6AAnv-5N6_s1HkzePJnncY19ajbQ-QanHMPjodvnNHVEM8Auj6shZOizNy0-v4O9h6eLz-ijM22CL2_zBN3_uPpzeV0sf_-8ufy-LBpe8lxoVkrruNWEOVVJCtQ6QYgCI0rNtGSVVZRzZStHuWGl5SMmqHSOCAlixU_Q2aF3iOHvDlKut2EXxy9SzSirpNRKsJFaHKgmhpQiuHqIvjPxuaakntzXk_t6cl9P7seD07fa3aoD-x9_l83_Ac4JgOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2127559842</pqid></control><display><type>article</type><title>Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ma, Chongyang ; Liu, Shuling ; Zhang, Shuang ; Xu, Tian ; Yu, Xue ; Gao, Yushan ; Zhai, Changming ; Li, Changxiang ; Lei, Chaofang ; Fan, Shuning ; Chen, Yuxi ; Tian, Huiling ; Wang, Qingguo ; Cheng, Fafeng ; Wang, Xueqian</creator><creatorcontrib>Ma, Chongyang ; Liu, Shuling ; Zhang, Shuang ; Xu, Tian ; Yu, Xue ; Gao, Yushan ; Zhai, Changming ; Li, Changxiang ; Lei, Chaofang ; Fan, Shuning ; Chen, Yuxi ; Tian, Huiling ; Wang, Qingguo ; Cheng, Fafeng ; Wang, Xueqian</creatorcontrib><description>Ischemic stroke is one of the main causes of death and disablement globally. The NLR family pyrin domain containing 3 (NLRP3) inflammasome is established as a sensor of detecting cellular damage and modulating inflammatory responses to injury during the progress of ischemic stroke. Inhibiting or blocking the NLRP3 inflammasome at different stages, including expression, assembly, and secretion, may have great promise to improve the neurological deficits during ischemic stroke. The current review provides a comprehensive summary of the current understanding in the literature of the molecular structure, expression, and assembly of the NLRP3 inflammasome, and highlights its potential as a novel therapeutic target for ischemic stroke.</description><identifier>ISSN: 1107-3756</identifier><identifier>EISSN: 1791-244X</identifier><identifier>DOI: 10.3892/ijmm.2018.3911</identifier><identifier>PMID: 30280193</identifier><language>eng</language><publisher>Greece: Spandidos Publications UK Ltd</publisher><subject>Animals ; Apoptosis ; Biomarkers ; Cardiovascular disease ; Cytokines ; Edema ; Gene Expression ; Humans ; Inflammasomes - metabolism ; Inflammation ; Ischemia ; Molecular Targeted Therapy ; Multiprotein Complexes - chemistry ; Multiprotein Complexes - metabolism ; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism ; Phosphorylation ; Proteins ; Rodents ; Signal Transduction ; Stroke - drug therapy ; Stroke - etiology ; Stroke - metabolism ; Stroke - pathology</subject><ispartof>International journal of molecular medicine, 2018-12, Vol.42 (6), p.2979-2990</ispartof><rights>Copyright Spandidos Publications UK Ltd. 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-9265df3d902f8751e1df4008ea46929527d81338d7f13a26d3f87415ff045e4b3</citedby><cites>FETCH-LOGICAL-c363t-9265df3d902f8751e1df4008ea46929527d81338d7f13a26d3f87415ff045e4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30280193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Chongyang</creatorcontrib><creatorcontrib>Liu, Shuling</creatorcontrib><creatorcontrib>Zhang, Shuang</creatorcontrib><creatorcontrib>Xu, Tian</creatorcontrib><creatorcontrib>Yu, Xue</creatorcontrib><creatorcontrib>Gao, Yushan</creatorcontrib><creatorcontrib>Zhai, Changming</creatorcontrib><creatorcontrib>Li, Changxiang</creatorcontrib><creatorcontrib>Lei, Chaofang</creatorcontrib><creatorcontrib>Fan, Shuning</creatorcontrib><creatorcontrib>Chen, Yuxi</creatorcontrib><creatorcontrib>Tian, Huiling</creatorcontrib><creatorcontrib>Wang, Qingguo</creatorcontrib><creatorcontrib>Cheng, Fafeng</creatorcontrib><creatorcontrib>Wang, Xueqian</creatorcontrib><title>Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)</title><title>International journal of molecular medicine</title><addtitle>Int J Mol Med</addtitle><description>Ischemic stroke is one of the main causes of death and disablement globally. The NLR family pyrin domain containing 3 (NLRP3) inflammasome is established as a sensor of detecting cellular damage and modulating inflammatory responses to injury during the progress of ischemic stroke. Inhibiting or blocking the NLRP3 inflammasome at different stages, including expression, assembly, and secretion, may have great promise to improve the neurological deficits during ischemic stroke. The current review provides a comprehensive summary of the current understanding in the literature of the molecular structure, expression, and assembly of the NLRP3 inflammasome, and highlights its potential as a novel therapeutic target for ischemic stroke.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Biomarkers</subject><subject>Cardiovascular disease</subject><subject>Cytokines</subject><subject>Edema</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Inflammasomes - metabolism</subject><subject>Inflammation</subject><subject>Ischemia</subject><subject>Molecular Targeted Therapy</subject><subject>Multiprotein Complexes - chemistry</subject><subject>Multiprotein Complexes - metabolism</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein - metabolism</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Signal Transduction</subject><subject>Stroke - drug therapy</subject><subject>Stroke - etiology</subject><subject>Stroke - metabolism</subject><subject>Stroke - pathology</subject><issn>1107-3756</issn><issn>1791-244X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kE1P3DAQhq2KqrvQXntElrjAIVt_JvaxQrQgrVqEisQt8sbjXS9JnNreRfwG_nQTFnqaV5pnXmkehL5SsuBKs29-23ULRqhacE3pBzSnlaYFE-LhaMyUVAWvZDlDxyltCWFSaPUJzThhilDN5-jlau8t9A1g01s8QEwDNNnvAbsQcd4AjqEFHNxr_rW8u-XY9641XWdS6AAnv-5N6_s1HkzePJnncY19ajbQ-QanHMPjodvnNHVEM8Auj6shZOizNy0-v4O9h6eLz-ijM22CL2_zBN3_uPpzeV0sf_-8ufy-LBpe8lxoVkrruNWEOVVJCtQ6QYgCI0rNtGSVVZRzZStHuWGl5SMmqHSOCAlixU_Q2aF3iOHvDlKut2EXxy9SzSirpNRKsJFaHKgmhpQiuHqIvjPxuaakntzXk_t6cl9P7seD07fa3aoD-x9_l83_Ac4JgOA</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Ma, Chongyang</creator><creator>Liu, Shuling</creator><creator>Zhang, Shuang</creator><creator>Xu, Tian</creator><creator>Yu, Xue</creator><creator>Gao, Yushan</creator><creator>Zhai, Changming</creator><creator>Li, Changxiang</creator><creator>Lei, Chaofang</creator><creator>Fan, Shuning</creator><creator>Chen, Yuxi</creator><creator>Tian, Huiling</creator><creator>Wang, Qingguo</creator><creator>Cheng, Fafeng</creator><creator>Wang, Xueqian</creator><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20181201</creationdate><title>Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)</title><author>Ma, Chongyang ; Liu, Shuling ; Zhang, Shuang ; Xu, Tian ; Yu, Xue ; Gao, Yushan ; Zhai, Changming ; Li, Changxiang ; Lei, Chaofang ; Fan, Shuning ; Chen, Yuxi ; Tian, Huiling ; Wang, Qingguo ; Cheng, Fafeng ; Wang, Xueqian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-9265df3d902f8751e1df4008ea46929527d81338d7f13a26d3f87415ff045e4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Biomarkers</topic><topic>Cardiovascular disease</topic><topic>Cytokines</topic><topic>Edema</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Inflammasomes - metabolism</topic><topic>Inflammation</topic><topic>Ischemia</topic><topic>Molecular Targeted Therapy</topic><topic>Multiprotein Complexes - chemistry</topic><topic>Multiprotein Complexes - metabolism</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein - metabolism</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Signal Transduction</topic><topic>Stroke - drug therapy</topic><topic>Stroke - etiology</topic><topic>Stroke - metabolism</topic><topic>Stroke - pathology</topic><toplevel>online_resources</toplevel><creatorcontrib>Ma, Chongyang</creatorcontrib><creatorcontrib>Liu, Shuling</creatorcontrib><creatorcontrib>Zhang, Shuang</creatorcontrib><creatorcontrib>Xu, Tian</creatorcontrib><creatorcontrib>Yu, Xue</creatorcontrib><creatorcontrib>Gao, Yushan</creatorcontrib><creatorcontrib>Zhai, Changming</creatorcontrib><creatorcontrib>Li, Changxiang</creatorcontrib><creatorcontrib>Lei, Chaofang</creatorcontrib><creatorcontrib>Fan, Shuning</creatorcontrib><creatorcontrib>Chen, Yuxi</creatorcontrib><creatorcontrib>Tian, Huiling</creatorcontrib><creatorcontrib>Wang, Qingguo</creatorcontrib><creatorcontrib>Cheng, Fafeng</creatorcontrib><creatorcontrib>Wang, Xueqian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Chongyang</au><au>Liu, Shuling</au><au>Zhang, Shuang</au><au>Xu, Tian</au><au>Yu, Xue</au><au>Gao, Yushan</au><au>Zhai, Changming</au><au>Li, Changxiang</au><au>Lei, Chaofang</au><au>Fan, Shuning</au><au>Chen, Yuxi</au><au>Tian, Huiling</au><au>Wang, Qingguo</au><au>Cheng, Fafeng</au><au>Wang, Xueqian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)</atitle><jtitle>International journal of molecular medicine</jtitle><addtitle>Int J Mol Med</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>42</volume><issue>6</issue><spage>2979</spage><epage>2990</epage><pages>2979-2990</pages><issn>1107-3756</issn><eissn>1791-244X</eissn><abstract>Ischemic stroke is one of the main causes of death and disablement globally. The NLR family pyrin domain containing 3 (NLRP3) inflammasome is established as a sensor of detecting cellular damage and modulating inflammatory responses to injury during the progress of ischemic stroke. Inhibiting or blocking the NLRP3 inflammasome at different stages, including expression, assembly, and secretion, may have great promise to improve the neurological deficits during ischemic stroke. The current review provides a comprehensive summary of the current understanding in the literature of the molecular structure, expression, and assembly of the NLRP3 inflammasome, and highlights its potential as a novel therapeutic target for ischemic stroke.</abstract><cop>Greece</cop><pub>Spandidos Publications UK Ltd</pub><pmid>30280193</pmid><doi>10.3892/ijmm.2018.3911</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1107-3756
ispartof International journal of molecular medicine, 2018-12, Vol.42 (6), p.2979-2990
issn 1107-3756
1791-244X
language eng
recordid cdi_proquest_journals_2127559842
source Spandidos Publications Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Apoptosis
Biomarkers
Cardiovascular disease
Cytokines
Edema
Gene Expression
Humans
Inflammasomes - metabolism
Inflammation
Ischemia
Molecular Targeted Therapy
Multiprotein Complexes - chemistry
Multiprotein Complexes - metabolism
NLR Family, Pyrin Domain-Containing 3 Protein - metabolism
Phosphorylation
Proteins
Rodents
Signal Transduction
Stroke - drug therapy
Stroke - etiology
Stroke - metabolism
Stroke - pathology
title Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T12%3A05%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20and%20perspective%20for%20the%20role%20of%20the%20NLRP3%20inflammasome%20signaling%20pathway%20in%20ischemic%20stroke%20and%20its%20therapeutic%20potential%20(Review)&rft.jtitle=International%20journal%20of%20molecular%20medicine&rft.au=Ma,%20Chongyang&rft.date=2018-12-01&rft.volume=42&rft.issue=6&rft.spage=2979&rft.epage=2990&rft.pages=2979-2990&rft.issn=1107-3756&rft.eissn=1791-244X&rft_id=info:doi/10.3892/ijmm.2018.3911&rft_dat=%3Cproquest_cross%3E2127559842%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2127559842&rft_id=info:pmid/30280193&rfr_iscdi=true